---
schema_version: "secwatch.filing_event.v1"
accession: "0001171843-26-003441"
form_type: "8-K"
ticker: "PROF"
cik: "0001628808"
company_name: "Profound Medical Corp."
filed_at: "2026-05-14T21:06:16+00:00"
generated_at: "2026-05-14T21:08:21.272509+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Profound Medical to present TULSA Procedure data at AUA2026 and explore PSMA PET integration

## Summary
- Four oral presentations on TULSA Procedure at AUA Annual Meeting in Washington, DC on May 16, 2026.
- Presenters include Mayo Clinic's Dr. Pathak, Dr. Anttinen (Finland), and Dr. Miura (Japan) covering registry, phase 2 trial, and real-world data.
- Launches initiative to explore integration of PSMA PET molecular imaging with TULSA-PRO software for treatment planning and monitoring.
- Hosts demonstrations of TULSA-PRO and Siemens MAGNETOM Free.Max MR at booth #413 at AUA2026.
- Note: 0.55T MRI compatibility (Free.Max) not yet commercially available in all markets, including the U.S.

## SEC filing metadata
- accession: 0001171843-26-003441
- form_type: 8-K
- ticker: PROF
- cik: 0001628808
- company_name: Profound Medical Corp.
- filed_at: 2026-05-14T21:06:16+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1628808/000117184326003441/0001171843-26-003441-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1628808/000117184326003441/f8k_051426.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001171843-26-003441
- JSON: https://secwatch.observer/filing/0001171843-26-003441.json
- Plain text: https://secwatch.observer/filing/0001171843-26-003441.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.